ConvaTec Group PLC (LON:CTEC) had its price objective trimmed by Citigroup Inc. from GBX 290 ($3.83) to GBX 226 ($2.98) in a report published on Tuesday, October 17th. The firm currently has a neutral rating on the stock.
Other equities research analysts have also issued research reports about the company. Peel Hunt restated a buy rating and set a GBX 380 ($5.01) target price on shares of ConvaTec Group PLC in a research report on Thursday, August 3rd. Numis Securities Ltd lowered ConvaTec Group PLC to a reduce rating and cut their target price for the company from GBX 276 ($3.64) to GBX 260 ($3.43) in a research report on Tuesday, July 11th. Goldman Sachs Group, Inc. (The) restated a buy rating and set a GBX 340 ($4.49) target price on shares of ConvaTec Group PLC in a research report on Thursday, August 3rd. Deutsche Bank AG upped their target price on ConvaTec Group PLC from GBX 330 ($4.35) to GBX 335 ($4.42) and gave the company a buy rating in a research report on Monday, August 21st. Finally, J P Morgan Chase & Co cut their target price on ConvaTec Group PLC from GBX 318 ($4.20) to GBX 303 ($4.00) and set an overweight rating on the stock in a research report on Friday, August 4th. One analyst has rated the stock with a sell rating, six have given a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of GBX 266.70 ($3.52).
Shares of ConvaTec Group PLC (LON:CTEC) opened at 204.34 on Tuesday. ConvaTec Group PLC has a 12-month low of GBX 191.20 and a 12-month high of GBX 349.10. The firm’s market cap is GBX 3.99 billion. The company has a 50-day moving average of GBX 258.01 and a 200 day moving average of GBX 292.55.
WARNING: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of US and international copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/27/convatec-group-plc-ctec-given-new-gbx-226-price-target-at-citigroup-inc.html.
The company also recently declared a dividend, which was paid on Friday, October 20th. Shareholders of record on Thursday, September 7th were paid a dividend of GBX 1.06 ($0.01) per share. This represents a yield of 0.36%. The ex-dividend date of this dividend was Thursday, September 7th.
In other ConvaTec Group PLC news, insider Christopher Gent purchased 38,889 shares of ConvaTec Group PLC stock in a transaction that occurred on Wednesday, October 18th. The shares were bought at an average price of GBX 213 ($2.81) per share, for a total transaction of £82,833.57 ($109,307.96).
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.